Therapy Areas: Inflammatory Diseases
Alnylam Pharmaceuticals and Taiba Group Partner to Commercialize RNAi Therapeutics in the Gulf States
8 July 2020 - - Swiss RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) and UAE-based rare disease company taiba Middle East have formed a Distribution Agreement for both ONP...
ChromaDex, NIH-NIAID Rocky Mountain Laboratories Launch Study to Assess the Therapeutic Potential of Niagen in COVID-19 Animal Models
7 July 2020 - - US-based nutraceutical company ChromaDex Corp. (NASDAQ: CDXC) has launched a preclinical study in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), ...
Cyxone (publ) names new senior scientific Aadvisor
7 July 2020 - Cyxone (publ), a Sweden-based biotech company, has named Dr Maarten Kraan as its new senior scientific advisor for the company's project for Rabeximod in rheumatoid arthritis, it wa...
Dragonfly Therapeutics expands Bristol Myers Squibb collaboration
7 July 2020 - United States-based Dragonfly Therapeutics Inc has expanded its collaboration with Bristol Myers Squibb, a United States-based pharmaceutical company, to discover and produce Dragonfly&#...
Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Targets
6 July 2020 - - US-based Dragonfly Therapeutics, Inc has launched a new research collaboration with Bristol Myers Squibb to discover and develop Dragonfly's novel immunotherapies for multiple scl...
European Commission Grants Conditional Marketing Authorization for Gilead's Veklury for the Treatment of COVID-19
6 July 2020 - - The European Commission has granted conditional marketing authorisation for Veklury (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, US-based ...
Related Headlines

Menarini Ricerche Plans to Launch C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer

GoldenBiotech wins FDA approval to begin Phase 2 trial of Antroquinonol in COVID-19 patients in the US

Transcell Oncologics Launches New Portfolio, Transtoxbio, for Testing COVID-19 Vaccines and Drug Candidates

HSS expects anakinra to help select COVID-19 patients avoid mechanical ventilation

PEEL Therapeutics Sees Possible New Treatment for COVID-19

RevImmune Launches Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19

Health Canada Allows COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma's Oxygen Therapeutic in Phase IIa Clinical Trial

Cold Spring Harbor Laboratory states sticky, pathogen-trapping webs produced by neutrophils cells are associated with the most severe cases of COVID-19

Cytocom Completes Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial of CYTO-201 in COVID-19 Patients

Citius Receives FDA Response on Pre-Investigational New Drug Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome in Patients with COVID-19

Celltex Therapeutics Receives FDA Approval for Phase II Clinical Trial Using Mesenchymal Stem Cells as a Prophylactic Against COVID-19

EMD Serono Initiates First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms of Covid-19 Infection

Allergan and Molecular Partners receive FDA response regarding Abicipar pegol for neovascular AMD

Noxopharm Starts COVID-19 Trial Programme in Europe

Vizient Data Show 610% Increase in Demand for Dexamethasone after Study Shows Effectiveness for Patients Severely Ill with COVID-19